[S-8] Viemed Healthcare, Inc. Employee Benefit Plan Registration

Rhea-AI Filing Summary

Viemed Healthcare, Inc. filed a Form S-8 to register an additional 412,351 common shares for issuance under the Viemed Healthcare, Inc. 2024 Long Term Incentive Plan, as amended. The amendment adding these shares was approved by shareholders at the companys 2025 annual meeting on June 5, 2025. Upon effectiveness, the total shares available for issuance under the 2024 Plan will be 7,904,757. The filing incorporates by reference a prior S-8 filed on August 12, 2024 (File No. 333-281502). The registrant is identified as an accelerated filer and lists British Columbia as its jurisdiction of incorporation and Lafayette, Louisiana as its principal executive office.

Positive

• Registration of 412,351 additional common shares for the 2024 Long Term Incentive Plan allows the company to grant further equity awards.
• Shareholder approval of the plan amendment at the June 5, 2025 annual meeting is documented in the filing.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine shareholder-approved amendment increases equity available for incentive awards; procedural and governance disclosure is complete.

The filing documents a shareholder-approved amendment to the 2024 Long Term Incentive Plan adding 412,351 common shares, bringing the plans available pool to 7,904,757 shares. This is a standard Form S-8 registration that incorporates a prior S-8 by reference and attaches required opinions and consents. From a governance standpoint, the company followed shareholder approval and SEC registration procedures; the filing identifies the company as an accelerated filer and includes customary exhibits.

Compensation Plan Analyst

TL;DR: The amendment expands the equity available for long-term incentives, consistent with typical executive and employee compensation administration.

The document registers an additional 412,351 shares under the Viemed 2024 Long Term Incentive Plan, as approved at the June 5, 2025 shareholder meeting. The registration references the plans prior description in the 2025 proxy and incorporates a prior S-8 (File No. 333-281502). Exhibits include the plan amendment and legal and auditor consents, enabling the company to grant awards under the amended plan once effective.

As filed with the Securities and Exchange Commission on August 12, 2025.

Registration No. 333-

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM S-8

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

VIEMED HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

British Columbia, Canada

N/A

(State or Other Jurisdiction of Incorporation or Organization)

(I.R.S. Employer Identification No.)

625 E. Kaliste Saloom Rd. Lafayette, Louisiana 70508

(Address of Principal Executive Offices) (Zip Code)

VIEMED HEALTHCARE, INC. 2024 LONG TERM INCENTIVE PLAN

(Full Title of the Plan)

Name, Address and Telephone									Copy of Communications to:
Number of Agent for Service:
Trae Fitzgerald									E. James Cowen
Chief Financial Officer									Porter Hedges LLP
Viemed Healthcare, Inc.									1000 Main Street, 36th Floor
625 E. Kaliste Saloom Rd.									Houston, Texas 77002-6336
Lafayette, Louisiana 70508									(713) 226-6000
(337) 504-3802

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ☐			Accelerated filer ☒
Non-accelerated filer ☐ (Do not check if a smaller reporting company)			Smaller reporting company ☐
			Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

___________________________

EXPLANATORY NOTE

This Registration Statement on Form S-8 is filed by Viemed Healthcare, Inc. (the “Company”) to register an additional 412,351 common shares of the Company (the “Common Shares”) for issuance pursuant to the Viemed Healthcare, Inc. 2024 Long Term Incentive Plan, as amended (the “2024 Plan”). The 2024 Plan was described in the Company’s definitive Proxy Statement for its 2025 Annual Meeting of Shareholders held on June 5, 2025. An amendment to the 2024 Plan to add an additional 412,351 Common Shares to the 2024 Plan was approved by the Company’s shareholders at that meeting.

The 412,351 Common Shares being registered hereby are in addition to the Common Shares registered by the Company’s prior Registration Statement on Form S-8 (the “Prior Registration Statement”) filed on August 12, 2024 (File No. 333-281502). Pursuant to General Instruction E of Form S-8, the contents of the Prior Registration Statement are incorporated by reference herein except as otherwise amended or superseded hereby. Upon the effectiveness of this Registration Statement, the total number of Common Shares registered for issuance under the 2024 Plan will correspond to the aggregate 7,904,757 Common Shares available for issuance as of the date of the amendment to the Plan.

Item 8. Exhibits.

See Index to Exhibits, attached hereto, which Index to Exhibits is hereby incorporated into this Item 8.

SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Lafayette, State of Louisiana, on this 12th  day of August, 2025.

VIEMED HEALTHCARE, INC.
By:						/s/ Trae Fitzgerald
						Trae Fitzgerald
						Chief Financial Officer

POWER OF ATTORNEY

    KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Casey Hoyt, W. Todd Zehnder and Trae Fitzgerald, and each of them, either of whom may act without joinder of the other, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any or all pre- and post-effective amendments and supplements to this registration statement, and to file the same, or cause to be filed the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto such attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and each of them, or the substitute or substitutes of either of them, may lawfully do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.

Signature

Title

Date

/s/ Casey Hoyt

Chief Executive Officer and Director

August 12, 2025

Casey Hoyt

(Principal Executive Officer)

/s/ Trae Fitzgerald

Chief Financial Officer

August 12, 2025

Trae Fitzgerald

(Principal Financial Officer and Accounting Officer)

/s/ W. Todd Zehnder

Chief Operating Officer and Director

August 12, 2025

W. Todd Zehnder

/s/ Randy Dobbs

Chairman of the Board

August 12, 2025

Randy Dobbs

/s/ Dr. William Frazier

Director and Chief Medical Officer

August 12, 2025

Dr. William Frazier

/s/ Sabrina Heltz

Director

August 12, 2025

Sabrina Heltz

/s/ Nitin Kaushal

Director

August 12, 2025

Nitin Kaushal

/s/ Timothy Smokoff

Director

August 12, 2025

Timothy Smokoff

INDEX TO EXHIBITS

Exhibit Number						Description
4.1						Viemed Healthcare, Inc. 2024 Long Term Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on June 6, 2024).
4.2						First Amendment to Viemed Healthcare, Inc. 2024 Long Term Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on June 5, 2025).
*5.1						Opinion of DLA Piper (Canada) LLP.
*23.1						Consent of Ernst & Young LLP.
*23.3						Consent of DLA Piper (Canada) LLP (included in Exhibit 5.1).
*24.1						Power of Attorney (included on signature page of this registration statement).
*107.1						Calculation of Filing Fee Tables
*Filed herewith.

FAQ

What did Viemed Healthcare (VMD) register on Form S-8?

The company registered an additional 412,351 common shares for issuance under the 2024 Long Term Incentive Plan.

How many total shares will be available under the 2024 Plan after this filing?

Upon effectiveness, the total available for issuance under the 2024 Plan will be 7,904,757 common shares.

When was the amendment to add these shares approved?

The amendment adding the 412,351 shares was approved by shareholders at the companys annual meeting on June 5, 2025.

Does the filing reference any prior registrations?

Yes. The filing incorporates by reference the prior Form S-8 filed on August 12, 2024 (File No. 333-281502).

Where is Viemed Healthcare incorporated and where is its principal office?

The registrant lists its jurisdiction of incorporation as British Columbia, Canada and its principal executive office at 625 E. Kaliste Saloom Rd., Lafayette, Louisiana 70508.